Middle East, North Africa, Afghanistan & Pakistan vs Netherlands: Access to anti-retroviral drugs, male
Middle East, North Africa, Afghanistan & Pakistan
25.6%
in 2024
Netherlands
89.0%
in 2023
Middle East, North Africa, Afghanistan & Pakistan rank
17th
Netherlands rank
17th
Access to anti-retroviral drugs, male over time
- Middle East, North Africa, Afghanistan & Pakistan
- Netherlands
How they compare
Netherlands currently reports 89.0% against 25.6% in Middle East, North Africa, Afghanistan & Pakistan, a difference of 63.4%.
That makes Netherlands's figure about 3.5 times Middle East, North Africa, Afghanistan & Pakistan's.
Across all 24 years both countries report, Netherlands has been ahead every year.
Middle East, North Africa, Afghanistan & Pakistan ranks 17th and Netherlands ranks 17th of 19 groups.
Netherlands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Middle East, North Africa, Afghanistan & Pakistan | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.1% | 50.8% | 44.7% | Netherlands |
| 2010s | 12.2% | 76.8% | 64.6% | Netherlands |
| 2020s | 21.0% | 88.2% | 67.2% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Middle East, North Africa, Afghanistan & Pakistan or Netherlands?
- Netherlands, at 89.0% against 25.6% in Middle East, North Africa, Afghanistan & Pakistan as of 2023.
- What is the difference in access to anti-retroviral drugs, male between Middle East, North Africa, Afghanistan & Pakistan and Netherlands?
- 63.4%, with Netherlands ahead.
- How many years of comparable data are there for Middle East, North Africa, Afghanistan & Pakistan and Netherlands?
- 24 years are reported by both, from 2000 to 2023.
- How do Middle East, North Africa, Afghanistan & Pakistan and Netherlands rank globally for access to anti-retroviral drugs, male?
- Middle East, North Africa, Afghanistan & Pakistan ranks 17th and Netherlands ranks 17th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.